Prelude Capital Management, LLC Gilead Sciences, Inc. Transaction History

Prelude Capital Management, LLC

$1.39 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $316,767 - $356,774	-5,488 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $722,088 - $904,854	-12,467 Reduced 69.43%	5,488 $326,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $1.16 Million - $1.32 Million	17,955 New	17,955 $1.3 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $1.45 Million - $1.59 Million	-22,921 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $892,500 - $1.02 Million	14,875 Added 184.87%	22,921 $1.48 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $62,654 - $71,392	1,106 Added 15.94%	8,046 $469,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $81,785 - $102,831	-1,317 Reduced 15.95%	6,940 $439,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $1.14 Million - $1.33 Million	-15,779 Reduced 65.65%	8,257 $635,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $702,708 - $900,068	11,220 Added 87.55%	24,036 $1.8 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $789,721 - $868,668	12,816 New	12,816 $833,000
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $1.85 Million - $2.04 Million	-29,524 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $396,029 - $444,101	6,401 Added 27.68%	29,524 $2 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $1.22 Million - $1.36 Million	-19,436 Reduced 45.67%	23,123 $1.5 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $1.38 Million - $1.8 Million	22,769 Added 115.05%	42,559 $2.66 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $189,177 - $209,453	-2,654 Reduced 11.82%	19,790 $1.53 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $1.13 Million - $1.32 Million	17,432 Added 347.81%	22,444 $1.59 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $582,865 - $710,577	-8,002 Reduced 61.49%	5,012 $378,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $259,555 - $304,680	3,648 Added 38.95%	13,014 $932,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $675,382 - $800,512	9,366	9,366 $759,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

Black Rock Inc. New York, NY

121M
Shares

$10.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$9.64 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.38 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.05 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$4.96 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account